line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,MEDICAMEQ.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.336468,MEDICAMEQ.NS
Normalized EBITDA,2025-03-31 00:00:00,201113000.0,MEDICAMEQ.NS
Total Unusual Items,2025-03-31 00:00:00,0.0,MEDICAMEQ.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,0.0,MEDICAMEQ.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,71082000.0,MEDICAMEQ.NS
Reconciled Depreciation,2025-03-31 00:00:00,70752000.0,MEDICAMEQ.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,846180000.0,MEDICAMEQ.NS
EBITDA,2025-03-31 00:00:00,201113000.0,MEDICAMEQ.NS
EBIT,2025-03-31 00:00:00,130361000.0,MEDICAMEQ.NS
Net Interest Income,2025-03-31 00:00:00,-31561000.0,MEDICAMEQ.NS
Interest Expense,2025-03-31 00:00:00,31561000.0,MEDICAMEQ.NS
Interest Income,2025-03-31 00:00:00,,MEDICAMEQ.NS
Normalized Income,2025-03-31 00:00:00,71082000.0,MEDICAMEQ.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,71082000.0,MEDICAMEQ.NS
Total Expenses,2025-03-31 00:00:00,1557549000.0,MEDICAMEQ.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,MEDICAMEQ.NS
Diluted Average Shares,2025-03-31 00:00:00,13775581.0,MEDICAMEQ.NS
Basic Average Shares,2025-03-31 00:00:00,13775581.0,MEDICAMEQ.NS
Diluted EPS,2025-03-31 00:00:00,5.16,MEDICAMEQ.NS
Basic EPS,2025-03-31 00:00:00,5.16,MEDICAMEQ.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,71082000.0,MEDICAMEQ.NS
Net Income Common Stockholders,2025-03-31 00:00:00,71082000.0,MEDICAMEQ.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,MEDICAMEQ.NS
Net Income,2025-03-31 00:00:00,71082000.0,MEDICAMEQ.NS
Minority Interests,2025-03-31 00:00:00,5525000.0,MEDICAMEQ.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,65557000.0,MEDICAMEQ.NS
Net Income Continuous Operations,2025-03-31 00:00:00,65557000.0,MEDICAMEQ.NS
Tax Provision,2025-03-31 00:00:00,33243000.0,MEDICAMEQ.NS
Pretax Income,2025-03-31 00:00:00,98800000.0,MEDICAMEQ.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,62439000.0,MEDICAMEQ.NS
Special Income Charges,2025-03-31 00:00:00,0.0,MEDICAMEQ.NS
Other Special Charges,2025-03-31 00:00:00,,MEDICAMEQ.NS
Write Off,2025-03-31 00:00:00,,MEDICAMEQ.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-31561000.0,MEDICAMEQ.NS
Total Other Finance Cost,2025-03-31 00:00:00,,MEDICAMEQ.NS
Interest Expense Non Operating,2025-03-31 00:00:00,31561000.0,MEDICAMEQ.NS
Interest Income Non Operating,2025-03-31 00:00:00,,MEDICAMEQ.NS
Operating Income,2025-03-31 00:00:00,67923000.0,MEDICAMEQ.NS
Operating Expense,2025-03-31 00:00:00,711369000.0,MEDICAMEQ.NS
Other Operating Expenses,2025-03-31 00:00:00,321979000.0,MEDICAMEQ.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,70661000.0,MEDICAMEQ.NS
Amortization,2025-03-31 00:00:00,,MEDICAMEQ.NS
Depreciation Income Statement,2025-03-31 00:00:00,70661000.0,MEDICAMEQ.NS
Selling General And Administration,2025-03-31 00:00:00,,MEDICAMEQ.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,MEDICAMEQ.NS
General And Administrative Expense,2025-03-31 00:00:00,,MEDICAMEQ.NS
Rent And Landing Fees,2025-03-31 00:00:00,,MEDICAMEQ.NS
Gross Profit,2025-03-31 00:00:00,779292000.0,MEDICAMEQ.NS
Cost Of Revenue,2025-03-31 00:00:00,846180000.0,MEDICAMEQ.NS
Total Revenue,2025-03-31 00:00:00,1625472000.0,MEDICAMEQ.NS
Operating Revenue,2025-03-31 00:00:00,1625472000.0,MEDICAMEQ.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,MEDICAMEQ.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.273915,MEDICAMEQ.NS
Normalized EBITDA,2024-03-31 00:00:00,245660000.0,MEDICAMEQ.NS
Total Unusual Items,2024-03-31 00:00:00,0.0,MEDICAMEQ.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,0.0,MEDICAMEQ.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,109310000.0,MEDICAMEQ.NS
Reconciled Depreciation,2024-03-31 00:00:00,70932000.0,MEDICAMEQ.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,925977000.0,MEDICAMEQ.NS
EBITDA,2024-03-31 00:00:00,245660000.0,MEDICAMEQ.NS
EBIT,2024-03-31 00:00:00,174728000.0,MEDICAMEQ.NS
Net Interest Income,2024-03-31 00:00:00,-43972000.0,MEDICAMEQ.NS
Interest Expense,2024-03-31 00:00:00,43972000.0,MEDICAMEQ.NS
Interest Income,2024-03-31 00:00:00,7243000.0,MEDICAMEQ.NS
Normalized Income,2024-03-31 00:00:00,109310000.0,MEDICAMEQ.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,109310000.0,MEDICAMEQ.NS
Total Expenses,2024-03-31 00:00:00,1641591000.0,MEDICAMEQ.NS
Rent Expense Supplemental,2024-03-31 00:00:00,,MEDICAMEQ.NS
Diluted Average Shares,2024-03-31 00:00:00,14574667.0,MEDICAMEQ.NS
Basic Average Shares,2024-03-31 00:00:00,14574667.0,MEDICAMEQ.NS
Diluted EPS,2024-03-31 00:00:00,7.5,MEDICAMEQ.NS
Basic EPS,2024-03-31 00:00:00,7.5,MEDICAMEQ.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,109310000.0,MEDICAMEQ.NS
Net Income Common Stockholders,2024-03-31 00:00:00,109310000.0,MEDICAMEQ.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,MEDICAMEQ.NS
Net Income,2024-03-31 00:00:00,109310000.0,MEDICAMEQ.NS
Minority Interests,2024-03-31 00:00:00,14370000.0,MEDICAMEQ.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,94940000.0,MEDICAMEQ.NS
Net Income Continuous Operations,2024-03-31 00:00:00,94940000.0,MEDICAMEQ.NS
Tax Provision,2024-03-31 00:00:00,35816000.0,MEDICAMEQ.NS
Pretax Income,2024-03-31 00:00:00,130756000.0,MEDICAMEQ.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,23257000.0,MEDICAMEQ.NS
Special Income Charges,2024-03-31 00:00:00,0.0,MEDICAMEQ.NS
Other Special Charges,2024-03-31 00:00:00,-733000.0,MEDICAMEQ.NS
Write Off,2024-03-31 00:00:00,,MEDICAMEQ.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-43972000.0,MEDICAMEQ.NS
Total Other Finance Cost,2024-03-31 00:00:00,,MEDICAMEQ.NS
Interest Expense Non Operating,2024-03-31 00:00:00,43972000.0,MEDICAMEQ.NS
Interest Income Non Operating,2024-03-31 00:00:00,7243000.0,MEDICAMEQ.NS
Operating Income,2024-03-31 00:00:00,151471000.0,MEDICAMEQ.NS
Operating Expense,2024-03-31 00:00:00,715614000.0,MEDICAMEQ.NS
Other Operating Expenses,2024-03-31 00:00:00,344024000.0,MEDICAMEQ.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,70932000.0,MEDICAMEQ.NS
Amortization,2024-03-31 00:00:00,1744000.0,MEDICAMEQ.NS
Depreciation Income Statement,2024-03-31 00:00:00,70932000.0,MEDICAMEQ.NS
Selling General And Administration,2024-03-31 00:00:00,,MEDICAMEQ.NS
Selling And Marketing Expense,2024-03-31 00:00:00,,MEDICAMEQ.NS
General And Administrative Expense,2024-03-31 00:00:00,,MEDICAMEQ.NS
Rent And Landing Fees,2024-03-31 00:00:00,,MEDICAMEQ.NS
Gross Profit,2024-03-31 00:00:00,867085000.0,MEDICAMEQ.NS
Cost Of Revenue,2024-03-31 00:00:00,925977000.0,MEDICAMEQ.NS
Total Revenue,2024-03-31 00:00:00,1793062000.0,MEDICAMEQ.NS
Operating Revenue,2024-03-31 00:00:00,1793062000.0,MEDICAMEQ.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,-1220698.327955,MEDICAMEQ.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.135905,MEDICAMEQ.NS
Normalized EBITDA,2023-03-31 00:00:00,272325000.0,MEDICAMEQ.NS
Total Unusual Items,2023-03-31 00:00:00,-8982000.0,MEDICAMEQ.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,-8982000.0,MEDICAMEQ.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,148441000.0,MEDICAMEQ.NS
Reconciled Depreciation,2023-03-31 00:00:00,63666000.0,MEDICAMEQ.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,859915000.0,MEDICAMEQ.NS
EBITDA,2023-03-31 00:00:00,263343000.0,MEDICAMEQ.NS
EBIT,2023-03-31 00:00:00,199677000.0,MEDICAMEQ.NS
Net Interest Income,2023-03-31 00:00:00,-26712000.0,MEDICAMEQ.NS
Interest Expense,2023-03-31 00:00:00,29227000.0,MEDICAMEQ.NS
Interest Income,2023-03-31 00:00:00,7207000.0,MEDICAMEQ.NS
Normalized Income,2023-03-31 00:00:00,156202301.672045,MEDICAMEQ.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,148441000.0,MEDICAMEQ.NS
Total Expenses,2023-03-31 00:00:00,1219779000.0,MEDICAMEQ.NS
Rent Expense Supplemental,2023-03-31 00:00:00,3976000.0,MEDICAMEQ.NS
Diluted Average Shares,2023-03-31 00:00:00,12651100.0,MEDICAMEQ.NS
Basic Average Shares,2023-03-31 00:00:00,12651100.0,MEDICAMEQ.NS
Diluted EPS,2023-03-31 00:00:00,11.733446,MEDICAMEQ.NS
Basic EPS,2023-03-31 00:00:00,11.733446,MEDICAMEQ.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,148441000.0,MEDICAMEQ.NS
Net Income Common Stockholders,2023-03-31 00:00:00,148441000.0,MEDICAMEQ.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,MEDICAMEQ.NS
Net Income,2023-03-31 00:00:00,148441000.0,MEDICAMEQ.NS
Minority Interests,2023-03-31 00:00:00,1156000.0,MEDICAMEQ.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,147285000.0,MEDICAMEQ.NS
Net Income Continuous Operations,2023-03-31 00:00:00,147285000.0,MEDICAMEQ.NS
Tax Provision,2023-03-31 00:00:00,23165000.0,MEDICAMEQ.NS
Pretax Income,2023-03-31 00:00:00,170450000.0,MEDICAMEQ.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,2490000.0,MEDICAMEQ.NS
Special Income Charges,2023-03-31 00:00:00,-8982000.0,MEDICAMEQ.NS
Other Special Charges,2023-03-31 00:00:00,-99000.0,MEDICAMEQ.NS
Write Off,2023-03-31 00:00:00,9081000.0,MEDICAMEQ.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-26712000.0,MEDICAMEQ.NS
Total Other Finance Cost,2023-03-31 00:00:00,4692000.0,MEDICAMEQ.NS
Interest Expense Non Operating,2023-03-31 00:00:00,29227000.0,MEDICAMEQ.NS
Interest Income Non Operating,2023-03-31 00:00:00,7207000.0,MEDICAMEQ.NS
Operating Income,2023-03-31 00:00:00,188895000.0,MEDICAMEQ.NS
Operating Expense,2023-03-31 00:00:00,359864000.0,MEDICAMEQ.NS
Other Operating Expenses,2023-03-31 00:00:00,2967000.0,MEDICAMEQ.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,63666000.0,MEDICAMEQ.NS
Amortization,2023-03-31 00:00:00,1103000.0,MEDICAMEQ.NS
Depreciation Income Statement,2023-03-31 00:00:00,62563000.0,MEDICAMEQ.NS
Selling General And Administration,2023-03-31 00:00:00,82747000.0,MEDICAMEQ.NS
Selling And Marketing Expense,2023-03-31 00:00:00,38929000.0,MEDICAMEQ.NS
General And Administrative Expense,2023-03-31 00:00:00,43818000.0,MEDICAMEQ.NS
Rent And Landing Fees,2023-03-31 00:00:00,3976000.0,MEDICAMEQ.NS
Gross Profit,2023-03-31 00:00:00,548759000.0,MEDICAMEQ.NS
Cost Of Revenue,2023-03-31 00:00:00,859915000.0,MEDICAMEQ.NS
Total Revenue,2023-03-31 00:00:00,1408674000.0,MEDICAMEQ.NS
Operating Revenue,2023-03-31 00:00:00,1408674000.0,MEDICAMEQ.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-1193514.739041,MEDICAMEQ.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.176686,MEDICAMEQ.NS
Normalized EBITDA,2022-03-31 00:00:00,259423000.0,MEDICAMEQ.NS
Total Unusual Items,2022-03-31 00:00:00,-6755000.0,MEDICAMEQ.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-6755000.0,MEDICAMEQ.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,148977000.0,MEDICAMEQ.NS
Reconciled Depreciation,2022-03-31 00:00:00,57714000.0,MEDICAMEQ.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,674574000.0,MEDICAMEQ.NS
EBITDA,2022-03-31 00:00:00,252668000.0,MEDICAMEQ.NS
EBIT,2022-03-31 00:00:00,194954000.0,MEDICAMEQ.NS
Net Interest Income,2022-03-31 00:00:00,-18057000.0,MEDICAMEQ.NS
Interest Expense,2022-03-31 00:00:00,14006000.0,MEDICAMEQ.NS
Interest Income,2022-03-31 00:00:00,1354000.0,MEDICAMEQ.NS
Normalized Income,2022-03-31 00:00:00,154538485.260959,MEDICAMEQ.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,148977000.0,MEDICAMEQ.NS
Total Expenses,2022-03-31 00:00:00,964459000.0,MEDICAMEQ.NS
Rent Expense Supplemental,2022-03-31 00:00:00,2527000.0,MEDICAMEQ.NS
Diluted Average Shares,2022-03-31 00:00:00,12216600.0,MEDICAMEQ.NS
Basic Average Shares,2022-03-31 00:00:00,12216600.0,MEDICAMEQ.NS
Diluted EPS,2022-03-31 00:00:00,12.19,MEDICAMEQ.NS
Basic EPS,2022-03-31 00:00:00,12.19,MEDICAMEQ.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,148977000.0,MEDICAMEQ.NS
Net Income Common Stockholders,2022-03-31 00:00:00,148977000.0,MEDICAMEQ.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,MEDICAMEQ.NS
Net Income,2022-03-31 00:00:00,148977000.0,MEDICAMEQ.NS
Minority Interests,2022-03-31 00:00:00,0.0,MEDICAMEQ.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,148977000.0,MEDICAMEQ.NS
Net Income Continuous Operations,2022-03-31 00:00:00,148977000.0,MEDICAMEQ.NS
Tax Provision,2022-03-31 00:00:00,31971000.0,MEDICAMEQ.NS
Pretax Income,2022-03-31 00:00:00,180948000.0,MEDICAMEQ.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,1276000.0,MEDICAMEQ.NS
Special Income Charges,2022-03-31 00:00:00,-6772000.0,MEDICAMEQ.NS
Other Special Charges,2022-03-31 00:00:00,-60000.0,MEDICAMEQ.NS
Write Off,2022-03-31 00:00:00,6832000.0,MEDICAMEQ.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-18057000.0,MEDICAMEQ.NS
Total Other Finance Cost,2022-03-31 00:00:00,5405000.0,MEDICAMEQ.NS
Interest Expense Non Operating,2022-03-31 00:00:00,14006000.0,MEDICAMEQ.NS
Interest Income Non Operating,2022-03-31 00:00:00,1354000.0,MEDICAMEQ.NS
Operating Income,2022-03-31 00:00:00,189994000.0,MEDICAMEQ.NS
Operating Expense,2022-03-31 00:00:00,289885000.0,MEDICAMEQ.NS
Other Operating Expenses,2022-03-31 00:00:00,4645000.0,MEDICAMEQ.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,57714000.0,MEDICAMEQ.NS
Amortization,2022-03-31 00:00:00,993000.0,MEDICAMEQ.NS
Depreciation Income Statement,2022-03-31 00:00:00,56721000.0,MEDICAMEQ.NS
Selling General And Administration,2022-03-31 00:00:00,77203000.0,MEDICAMEQ.NS
Selling And Marketing Expense,2022-03-31 00:00:00,32377000.0,MEDICAMEQ.NS
General And Administrative Expense,2022-03-31 00:00:00,44826000.0,MEDICAMEQ.NS
Rent And Landing Fees,2022-03-31 00:00:00,2527000.0,MEDICAMEQ.NS
Gross Profit,2022-03-31 00:00:00,479879000.0,MEDICAMEQ.NS
Cost Of Revenue,2022-03-31 00:00:00,674574000.0,MEDICAMEQ.NS
Total Revenue,2022-03-31 00:00:00,1154453000.0,MEDICAMEQ.NS
Operating Revenue,2022-03-31 00:00:00,1154453000.0,MEDICAMEQ.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,MEDICAMEQ.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,MEDICAMEQ.NS
Normalized EBITDA,2021-03-31 00:00:00,,MEDICAMEQ.NS
Total Unusual Items,2021-03-31 00:00:00,,MEDICAMEQ.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,MEDICAMEQ.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,MEDICAMEQ.NS
Reconciled Depreciation,2021-03-31 00:00:00,,MEDICAMEQ.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,MEDICAMEQ.NS
EBITDA,2021-03-31 00:00:00,,MEDICAMEQ.NS
EBIT,2021-03-31 00:00:00,,MEDICAMEQ.NS
Net Interest Income,2021-03-31 00:00:00,,MEDICAMEQ.NS
Interest Expense,2021-03-31 00:00:00,,MEDICAMEQ.NS
Interest Income,2021-03-31 00:00:00,1533089.0,MEDICAMEQ.NS
Normalized Income,2021-03-31 00:00:00,,MEDICAMEQ.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,MEDICAMEQ.NS
Total Expenses,2021-03-31 00:00:00,,MEDICAMEQ.NS
Rent Expense Supplemental,2021-03-31 00:00:00,2161746.0,MEDICAMEQ.NS
Diluted Average Shares,2021-03-31 00:00:00,,MEDICAMEQ.NS
Basic Average Shares,2021-03-31 00:00:00,,MEDICAMEQ.NS
Diluted EPS,2021-03-31 00:00:00,,MEDICAMEQ.NS
Basic EPS,2021-03-31 00:00:00,,MEDICAMEQ.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,MEDICAMEQ.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,MEDICAMEQ.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,MEDICAMEQ.NS
Net Income,2021-03-31 00:00:00,,MEDICAMEQ.NS
Minority Interests,2021-03-31 00:00:00,,MEDICAMEQ.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,MEDICAMEQ.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,MEDICAMEQ.NS
Tax Provision,2021-03-31 00:00:00,,MEDICAMEQ.NS
Pretax Income,2021-03-31 00:00:00,,MEDICAMEQ.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,MEDICAMEQ.NS
Special Income Charges,2021-03-31 00:00:00,,MEDICAMEQ.NS
Other Special Charges,2021-03-31 00:00:00,-27285.0,MEDICAMEQ.NS
Write Off,2021-03-31 00:00:00,0.0,MEDICAMEQ.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,MEDICAMEQ.NS
Total Other Finance Cost,2021-03-31 00:00:00,4475117.0,MEDICAMEQ.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,MEDICAMEQ.NS
Interest Income Non Operating,2021-03-31 00:00:00,1533089.0,MEDICAMEQ.NS
Operating Income,2021-03-31 00:00:00,,MEDICAMEQ.NS
Operating Expense,2021-03-31 00:00:00,,MEDICAMEQ.NS
Other Operating Expenses,2021-03-31 00:00:00,,MEDICAMEQ.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,MEDICAMEQ.NS
Amortization,2021-03-31 00:00:00,649600.0,MEDICAMEQ.NS
Depreciation Income Statement,2021-03-31 00:00:00,,MEDICAMEQ.NS
Selling General And Administration,2021-03-31 00:00:00,41531215.0,MEDICAMEQ.NS
Selling And Marketing Expense,2021-03-31 00:00:00,16110913.0,MEDICAMEQ.NS
General And Administrative Expense,2021-03-31 00:00:00,25420302.0,MEDICAMEQ.NS
Rent And Landing Fees,2021-03-31 00:00:00,2161746.0,MEDICAMEQ.NS
Gross Profit,2021-03-31 00:00:00,,MEDICAMEQ.NS
Cost Of Revenue,2021-03-31 00:00:00,,MEDICAMEQ.NS
Total Revenue,2021-03-31 00:00:00,,MEDICAMEQ.NS
Operating Revenue,2021-03-31 00:00:00,,MEDICAMEQ.NS
